Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique (Q34563176)

3 August 2017

1 reference

title

Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique (English)

1 reference

3 August 2017

0 references

M Karen Campbell

2

0 references

Jessica M Sontrop

series ordinal

1

object named as

Jessica Sontrop

1 reference

PubMed ID

16337677

3 August 2017

language of work or name

English

0 references

publication date

7 December 2005

1 reference

3 August 2017

1 reference

3 August 2017

42

1 reference

3 August 2017

1

1 reference

3 August 2017

4-13

1 reference

Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Relation between birth order and the maternal and neonatal docosahexaenoic acid status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Biomarkers of fat and fatty acid intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: the Tromsø study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fish oils and bipolar disorder: a promising but untested treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

omega 3 polyunsaturated fatty acids, inflammation and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega-3 fatty acids for depression in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Long chain polyunsaturated fatty acids in endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Diet and socioeconomic position: does the use of different indicators matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Food and nutrient intake in relation to mental wellbeing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Is low dietary intake of omega-3 fatty acids associated with depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fish consumption and major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega 3 fatty acid status in patients with retinitis pigmentosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Essentiality of dietary omega 3 fatty acids for premature infants: plasma and red blood cell fatty acid composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Essential fatty acids in mothers and their neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Health benefits of docosahexaenoic acid (DHA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Polyunsaturated fatty acids in the food chain in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

A new era for science in nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Elevated levels of prostaglandin E2 and thromboxane B2 in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The monocyte-T-lymphocyte hypothesis of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Depression and adipose essential polyunsaturated fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Behavioral assessment of patients treated with alpha-interferon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega-3 Eicosapentaenoic Acid in Bipolar Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The effects of cigarette smoking on the metabolism of essential fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Bias in analytic research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Polyunsaturated fatty acids in the food chain in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fish consumption and self-reported physical and mental health status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega-3 fatty acids in inflammation and autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The importance of the ratio of omega-6/omega-3 essential fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Diets rich in lean beef increase arachidonic acid and long-chain omega 3 polyunsaturated fatty acid levels in plasma phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The macrophage theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Methodological considerations in clinical studies of omega 3 fatty acids in major depression and bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The 2 "Es" of research: efficacy and effectiveness trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Evidence for a role of the arachidonic acid cascade in affective disorders: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Polyunsaturated fatty acids in the food chain in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fish consumption, depression, and suicidality in a general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Fish consumption and depressive symptoms in the general population in Finland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

The female docosahexaenoic acid status related to the number of completed pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Statistics notes: Analysing controlled trials with baseline and follow up measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Selection of controls in case-control studies. III. Design options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Placebo response in studies of major depression: variable, substantial, and growing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

Depressive symptoms during pregnancy: relationship to poor health behaviors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2005.11.005

10.1016/J.YPMED.2005.11.005

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

16337677